Dyne Therapeutics
Price & Volume
Stats
See more52W Range | $6.36-$35.68 |
Market Cap | $2.6B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.62 |
News
See moreYahoo Finance • 5 days ago
Dyne Therapeutics, Inc. Loss At -$108.14 Mln In Q3
Yahoo Finance • 5 days ago
Dyne Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Yahoo Finance • 7 days ago
Dyne Therapeutics to Present at Upcoming Investor Conferences
Yahoo Finance • 13 days ago
Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger
About
CEO | Mr. John G. Cox M.B.A. |
CFO | Mr. Erick J. Lucera C.F.A., CPA |
Address | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 191 |
